← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2009Last known activity
Nov 1, 2021
Timeline
2000s
- Jan 1, 2003
Institut de Cancérologie de la Loire (ICLN)— Founded
Drugs by trial phase (14 distinct, 7 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT05091684Lead sponsorPhase 2Nov 1, 2021
- NCT04250805Lead sponsorPhase 2Mar 1, 2020
- NCT03753776Lead sponsorPhase 3Jun 1, 2019
- NCT03801122Lead sponsorPhase 2Mar 5, 2019
- NCT03317613Lead sponsorPhase 2Nov 9, 2017
- NCT01116193Lead sponsorPhase 2Jan 1, 2010
- NCT01116193Overall official - principal investigatorPhase 2Jan 1, 2010
- NCT00985855Lead sponsorPhase 2Sep 1, 2009
Details
- Founded
- Saint-Priest-en-Jarez, FR Jan 1, 2003
- Last known activity
- Nov 1, 2021